Giulia C Kennedy Veracyte, Inc. (VCYT) insider trading activity

Giulia C Kennedy is Chief Scientific & Med Officer of VERACYTE, INC.. Currently has a direct ownership of 65,970 shares of VCYT, which is worth approximately $2.26 Million. The most recent transaction as insider was on Jun 23, 2021, when has been sold 4,375 shares (Common Stock) at a price of $24.69 per share, resulting in proceeds of $108,019. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66K

0% 3M change

0% 12M change

Total Value Held $2.26 Million

Giulia C Kennedy Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 23 2021	BUY Exercise of conversion of derivative security	$108,019 $24.69 p/Share	4,375 Added 7.22%	56,262 Common Stock
Jun 04 2021	SELL Open market or private sale	$311,297 $34.28 p/Share	9,081 Reduced 14.89%	51,887 Common Stock
Jun 04 2021	BUY Exercise of conversion of derivative security	$106,844 $13.1 p/Share	8,156 Added 11.8%	60,968 Common Stock
Jun 02 2021	SELL Payment of exercise price or tax liability	$32,896 $36.07 p/Share	912 Reduced 1.7%	52,812 Common Stock
Mar 04 2021	SELL Open market or private sale	$2,673,051 $51.39 p/Share	52,015 Reduced 49.19%	53,724 Common Stock
Mar 04 2021	BUY Exercise of conversion of derivative security	$463,931 $14.98 p/Share	30,970 Added 22.65%	105,739 Common Stock
Mar 02 2021	SELL Payment of exercise price or tax liability	$372,589 $62.15 p/Share	5,995 Reduced 7.42%	74,769 Common Stock
Feb 26 2021	BUY Grant, award, or other acquisition	-	12,500 Added 13.4%	80,764 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$625,990 $62.3 p/Share	10,048 Reduced 12.83%	68,264 Common Stock
Dec 04 2020	SELL Open market or private sale	$795,071 $56.73 p/Share	14,015 Reduced 15.18%	78,312 Common Stock
Dec 04 2020	BUY Exercise of conversion of derivative security	$158,249 $11.75 p/Share	13,468 Added 12.73%	92,327 Common Stock
Dec 02 2020	SELL Payment of exercise price or tax liability	$29,743 $55.08 p/Share	540 Reduced 0.68%	78,859 Common Stock
Oct 06 2020	SELL Open market or private sale	$88,025 $35.21 p/Share	2,500 Reduced 3.05%	79,399 Common Stock
Oct 06 2020	BUY Exercise of conversion of derivative security	$50,525 $20.21 p/Share	2,500 Added 2.96%	81,899 Common Stock

GCK

Giulia C Kennedy

Chief Scientific & Med Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VCYT shares.

Notify only if

Value

Insider Trading

Get notified when an Veracyte, Inc. insider buys or sells VCYT shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERACYTE, INC.

Track Activities on VCYT

Account